SHABNAM TABAROKI: Open Payments
NPI 1942437066 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 61 payments from 16 companies in 2025. Trend: 2023 $1,944 · 2024 $1,664 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $302 |
| Amgen Inc. | 7 | $222 |
| Merck Sharp & Dohme LLC | 8 | $204 |
| Abbott Laboratories | 2 | $148 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| PFIZER INC. | 5 | $100 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Edwards Lifesciences Corporation | 2 | $54 |
Products named: REPATHA, VERQUVO, CAMZYOS, CARDIOMEMS, ELIQUIS, LEQVIO, VYNDAQEL, MOUNJARO.
Industry payments across NY — which companies pay providers there.
